{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:02:32Z","timestamp":1761580952262},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.tripleo.2011.08.024","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T07:30:30Z","timestamp":1327735830000},"page":"234-238","source":"Crossref","is-referenced-by-count":62,"title":["Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: Report of 2 cases with clinical implications"],"prefix":"10.1016","volume":"113","author":[{"given":"Ourania","family":"Nicolatou-Galitis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalini","family":"Migkou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Psyrri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristotle","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Pectasides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theofanis","family":"Economopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith E.","family":"Raber-Durlacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meletios A.","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tripleo.2011.08.024_bib1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.clinthera.2007.07.022","article-title":"Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors","volume":"29","author":"Adams","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.tripleo.2011.08.024_bib2","first-page":"S41","article-title":"Sunitinib therapy for metastatic renal cell carcinoma: recommendations for management of side effects","volume":"1","author":"Kollmannsberger","year":"2007","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.tripleo.2011.08.024_bib3","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2407-9-82","article-title":"Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers","volume":"9","author":"Kontovinis","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tripleo.2011.08.024_bib4","first-page":"1","article-title":"Optimizing the use of sunitinib in metastatic renal cell carcinoma: an update from clinical practice","author":"Schmidinger","year":"2010","journal-title":"Cancer Invest"},{"key":"10.1016\/j.tripleo.2011.08.024_bib5","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1345\/aph.1K592","article-title":"Sunitinib adverse event: oral bullous and lichenoid mucositis","author":"Mignogna","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.tripleo.2011.08.024_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tripleo.2010.04.049","article-title":"Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases","volume":"110","author":"Hoefert","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2011.08.024_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bone.2008.08.132","article-title":"Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma","volume":"44","author":"Brunello","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.08.024_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10006-010-0224-y","article-title":"Osteonecrosis of the jaw related to sunitinib","volume":"15","author":"Koch","year":"2011","journal-title":"Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.08.024_bib9","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.tripleo.2011.08.024_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","article-title":"Position paper on bisphosphonate-related osteonecrosis of the jaw-2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.08.024_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00520-010-0882-1","article-title":"A systematic review of bisphosphonate osteonecrosis (BON) in cancer","volume":"18","author":"Migliorati","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tripleo.2011.08.024_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.tripleo.2011.02.037","article-title":"Osteonecrosis of the jaw (BRONJ) in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center","author":"Nicolatou-Galitis","year":"2011","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.tripleo.2011.08.024_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-0757.1994.tb00031.x","article-title":"Acute necrotizing ulcerative gingivitis: risk factors involving host defense mechanisms","volume":"6","author":"Murayama","year":"2000","journal-title":"Periodontol"},{"key":"10.1016\/j.tripleo.2011.08.024_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","article-title":"Osteonecrosis of the jaws induced by anti-RANK ligand therapy","volume":"48","author":"Taylor","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.08.024_bib15","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.bone.2010.10.048","volume":"48","author":"Brown","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.tripleo.2011.08.024_bib16","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"JCO"},{"key":"10.1016\/j.tripleo.2011.08.024_bib17","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1093\/annonc\/mdn653","article-title":"Bevacizumab-associated osteonecrosis of the jaw","volume":"19","author":"Greuter","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tripleo.2011.08.024_bib18","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.tripleo.2011.08.024_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/07357900802208608","article-title":"Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer with anti-angiogenic agents","volume":"27","author":"Aragon-Ching","year":"2009","journal-title":"Cancer Invest"},{"key":"10.1016\/j.tripleo.2011.08.024_bib20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1093\/annonc\/mdn788","article-title":"Ostenocrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?","volume":"20","author":"Ayllon","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tripleo.2011.08.024_bib21","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.oraloncology.2009.10.004","article-title":"Osteonecrosis of the jaws induced by drugs other than bisphosphonates\u2014a call to update terminology in light of new data","volume":"46","author":"Yarom","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.tripleo.2011.08.024_bib22","first-page":"e3","article-title":"Bisphosphonate related osteonecrosis of the jaw: a literature review and a new hypothesis","volume":"2","author":"Helsloot","year":"2001","journal-title":"Int J Oral Res"},{"key":"10.1016\/j.tripleo.2011.08.024_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.joms.2008.01.026","article-title":"Inhibition of oral mucosal cell wound healing by bisphopshonates","volume":"66","author":"Landesberg","year":"2008","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.08.024_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","article-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data","volume":"67","author":"Allen","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.tripleo.2011.08.024_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","article-title":"Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells","volume":"14","author":"Walter","year":"2010","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.tripleo.2011.08.024_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djq516","article-title":"Osteoneocrosis of the jaw and the role of macrophages","volume":"103","author":"Pazianas","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.tripleo.2011.08.024_bib27","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","article-title":"Migration of human monocytes in response to endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1","volume":"87","author":"Barleon","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2011.08.024_bib28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1182\/blood.V97.3.785","article-title":"Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans","volume":"97","author":"Sawano","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tripleo.2011.08.024_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/annonc\/mdn554","article-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zolendronic acid","volume":"20","author":"Dimopoulos","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.tripleo.2011.08.024_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00520-005-0006-5","article-title":"Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis","volume":"14","author":"Nicolatou-Galitis","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tripleo.2011.08.024_bib31","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00520-005-0835-2","article-title":"Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy","volume":"14","author":"Nicolatou-Galitis","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tripleo.2011.08.024_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00520-010-1002-y","article-title":"Progress of oral care and reduction of oral mucositis\u2014a pilot study in a hematopoietic stem cell transplantation ward","volume":"19","author":"Soga","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.tripleo.2011.08.024_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1874079001104010007","article-title":"Oral mucositis, pain and xerostomia in 135 head and neck cancer patients receiving radiotherapy with or without chemotherapy","volume":"4","author":"Nicolatou-Galitis","year":"2011","journal-title":"Open Cancer J"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210411006226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210411006226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T09:53:21Z","timestamp":1593597201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210411006226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1079210411006226"],"URL":"https:\/\/doi.org\/10.1016\/j.tripleo.2011.08.024","relation":{},"ISSN":["2212-4403"],"issn-type":[{"value":"2212-4403","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}